In Conversation With… Glenn Philips, PhD
“We're using the same tools that demonstrate the benefit of our drugs to show that the long-term cost of steroids has been vastly underestimated.” Glenn Philips, PhD is the Vice President of Health ...
Quantifying the Risk-Benefit Ratio of Steroids in Myasthenia Gravis
A pioneering analysis of electronic health record (EHR) data from the Optum® EHR database has shown that it is finally possible to quantify the risk-to-benefit ratio of prescribing glucocorticoids, ...
Discovering Steroid-toxicity Secrets Concealed in Large Datasets
A challenge that has vexed health systems and payers for decades is the inability to fully quantify the long-term impacts of steroid-toxicity. Set to change that paradigm is the GTI-MD, an ...
75 Years of Steroid-Toxicity
On September 4, 1948, the first dose of a glucocorticoid was administered to a bed-ridden 24-year-old woman with rheumatoid arthritis. The treatment of rheumatoid arthritis with cortisone resulted in ...
Latest ACR guidelines highlight the risks of steroid-induced osteoporosis
More than 50 million people around the globe are prescribed glucocorticoids to help manage/treat their inflammatory diseases. The latest guidelines developed by the American College of Rheumatology ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
